Calypso Biotech raised €20M in a Series A round in Jan 2019. The company is based in Geneva, Netherlands. Investors in the round: Gilde Healthcare, INKEF Capital. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €20M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
